Daptomycin produced by Streptomyces roseosporus is an important lipopeptide antibiotic used to treat human infections caused by Gram-positive pathogenic bacteria, including drug-resistant strains. The genetic basis for regulatory mechanisms of daptomycin production is poorly known. Here, we characterized the dptR3 gene, which encodes a MarR family transcriptional regulator located adjacent to the known daptomycin biosynthetic (dpt) genes. Deletion of dptR3 reduced daptomycin production significantly and delayed aerial mycelium formation and sporulation on solid media. Dissection of the mechanism underlying the function of DptR3 in daptomycin production revealed that it stimulates daptomycin production indirectly by altering the transcription of dpt structural genes. DptR3 directly activated the transcription of its own gene, dptR3, but repressed the transcription of the adjacent, divergent gene orf16 (which encodes a putative ABC transporter ATP-binding protein). A 66-nucleotide DptR3-binding site in the intergenic region of dptR3-orf16 was determined by DNase I footprinting, and the palindromic sequence TCATTGTTACCTATGCTCACAATGA (underlining indicates inverted repeats) in the protected region was found to be essential for DptR3 binding. orf16, the major target gene of DptR3, exerted a positive effect on daptomycin biosynthesis. Our findings indicate that DptR3 functions as a global regulator that positively controls daptomycin production and morphological development in S. roseosporus.
Streptomycetes are soil-dwelling filamentous bacteria characterized by complex morphological differentiation and the ability to produce a variety of antibiotics. The production of these antibiotics is a complex process that is usually accompanied by morphological differentiation and is controlled by multiple regulatory proteins that respond to nutritional status, population density, and a variety of environmental conditions (1-3). Generally, the lowest level of the regulatory network involves pathway-specific regulatory genes that are found within the respective antibiotic biosynthesis gene cluster and affect only a single antibiotic biosynthetic pathway.Daptomycin is a cyclic lipopeptide antibiotic used clinically to treat complex skin infections caused by Gram-positive pathogens, including 15 genera and 35 species, notably, penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant Enterococcus spp., glycopeptide-insensitive Staphylococcus aureus, and methicillin-resistant S. aureus (4). Daptomycin is a minor component of the A21978C complex produced by Streptomyces roseosporus via a nonribosomal peptide synthetase (NRPS) mechanism. Components of the complex have in common a 10-membered cyclic peptide nucleus and a three-amino-acid tail with various fatty acid moieties attached to the N-terminal tryptophan (Trp) (5). The fatty acid portion of daptomycin is straight-chain decanoic acid, and daptomycin production can be increased by adding the precursor decanoic acid or sodium decanoate to the fermentation broth (6, 7).I...